I’ve got a bio-scientist cousin. He works for venture capitalists. They send him to drug labs to decide if a company should get a $20mm loan (typical example) to develop a drug that is showing promise. I’ll have to ask him if A.I. is going to get in his way as a competitor.
It would be interesting to hear what he thinks about AI and how it will affect the pharma industry. Keep me posted if possible.